摘要
背景和目的:硫氧还蛋白相互作用蛋白(TXNIP)也被称为硫氧还蛋白结合蛋白-2是一种普遍表达的蛋白质,其相互作用并负调节硫氧还蛋白(TXN)的表达和功能。在过去几年中,由于其广泛的功能影响了能量代谢的几个方面,TXNIP引起了相当大的关注。 TXNIP通过多效性作用,作为葡萄糖和脂质代谢的重要调节因子,包括调节β细胞功能,肝葡萄糖产生,外周葡萄糖摄取,脂肪形成和底物利用。动物模型中TXNIP的过度表达已被证明可诱导胰腺β细胞的凋亡,降低外周组织如骨骼肌和脂肪的胰岛素敏感性,并降低能量消耗。相反,TXNIP缺陷动物受到饮食诱导的胰岛素抵抗和2型糖尿病的保护。 总结:因此,目标TXNIP被认为提供新的治疗机会,并且TXNIP抑制剂有潜力成为治疗糖尿病的有力治疗工具。在这里,我们总结了我们对TXNIP生物学的了解的现状,突出了其在代谢调节中的作用,并提出了有助于未来研究利用TXNIP作为治疗靶点的关键问题。
关键词: 糖尿病,硫氧还蛋白系统,硫氧还蛋白相互作用蛋白,氧化应激,胰岛素抵抗,胰腺β细胞功能障碍,代谢稳态
图形摘要
Current Drug Targets
Title:TXNIP in Metabolic Regulation: Physiological Role and Therapeutic Outlook
Volume: 18 Issue: 9
关键词: 糖尿病,硫氧还蛋白系统,硫氧还蛋白相互作用蛋白,氧化应激,胰岛素抵抗,胰腺β细胞功能障碍,代谢稳态
摘要: Background & Objective: Thioredoxin-interacting protein (TXNIP) also known as thioredoxin binding protein-2 is a ubiquitously expressed protein that interacts and negatively regulates expression and function of Thioredoxin (TXN). Over the last few years, TXNIP has attracted considerable attention due to its wide-ranging functions impacting several aspects of energy metabolism. TXNIP acts as an important regulator of glucose and lipid metabolism through pleiotropic actions including regulation of β-cell function, hepatic glucose production, peripheral glucose uptake, adipogenesis, and substrate utilization. Overexpression of TXNIP in animal models has been shown to induce apoptosis of pancreatic β-cells, reduce insulin sensitivity in peripheral tissues like skeletal muscle and adipose, and decrease energy expenditure. On the contrary, TXNIP deficient animals are protected from diet induced insulin resistance and type 2 diabetes.
Summary: Consequently, targeting TXNIP is thought to offer novel therapeutic opportunity and TXNIP inhibitors have the potential to become a powerful therapeutic tool for the treatment of diabetes mellitus. Here we summarize the current state of our understanding of TXNIP biology, highlight its role in metabolic regulation and raise critical questions that could help future research to exploit TXNIP as a therapeutic target.Export Options
About this article
Cite this article as:
TXNIP in Metabolic Regulation: Physiological Role and Therapeutic Outlook, Current Drug Targets 2017; 18 (9) . https://dx.doi.org/10.2174/1389450118666170130145514
DOI https://dx.doi.org/10.2174/1389450118666170130145514 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Measurement of Physical Changes in the Myocardium for Development of Novel Methods for Diagnosing Ischemia
Current Cardiology Reviews Decoding the Transcriptional Response to Ischemic Stroke in Obese and Non-obese Mice Brain
Current Neurovascular Research 3D-QSAR Assisted Design of Novel 7-Deazapurine Derivatives as TNNI3K Kinase Inhibitors Using Molecular Docking and Molecular Dynamics Simulation
Letters in Drug Design & Discovery Current Perspectives on Anti-Aging Interventions
Letters in Drug Design & Discovery The Role of the Chemokines in Myocardial Ischemia and Reperfusion
Current Vascular Pharmacology Is Nephrogenic Systemic Fibrosis a Disease of Fibrocytes?
Current Rheumatology Reviews Nitric Oxide in Cardiac Transplantation
Vascular Disease Prevention (Discontinued) MicroRNAs and the Heart: Small Things Do Matter
Current Topics in Medicinal Chemistry Hypothyroidism and Endothelial Function: A Marker of Early Atherosclerosis?
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Endothelial Microparticles: Mediators or Markers of Endothelial Cell Dysfunction?
Current Hypertension Reviews Editorial [Hot Topic:Applications of Angiotensin Converting Enzyme Inhibitors and of Angiotensin II Receptor Blockers in Pharmacology and Therapy: An Update (Executive Editor: Agostino Molteni)]
Current Pharmaceutical Design Tako-tsubo Cardiomyopathy: A Review of the Literature
Current Cardiology Reviews Chemotherapy and Targeted Agents for Elderly Women with Advanced Breast Cancer
Recent Patents on Anti-Cancer Drug Discovery Dynamic Crosstalk between GlcNAcylation and Phosphorylation: Roles in Signaling, Transcription and Human Disease
Current Signal Transduction Therapy Advances in Characterization of Human Sirtuin Isoforms: Chemistries, Targets and Therapeutic Applications
Current Medicinal Chemistry Roles of IL-6-gp130 Signaling in Vascular Inflammation
Current Cardiology Reviews A Review of Natural and Synthetic Antioxidants Important for Health and Longevity
Current Medicinal Chemistry Modular Nanotransporters for Targeted Intracellular Delivery of Drugs: Folate Receptors as Potential Targets
Current Pharmaceutical Design Cell Therapy for the Treatment of Chronic Ischemic Heart Disease
Current Pharmaceutical Design Common Comorbidities that Alter Heart Failure Prognosis - Shaping New Thinking for Practice
Current Cardiology Reviews